Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development
– Brings more than 20 years of oncology business development and commercial leadership, including senior roles across the radiopharmaceutical sector at Bayer, Clovis Oncology, Telix Pharmaceuticals and BWXT Medical – Will lead partnering, licensing and strategic transactions across...
Covered in this story
Call it yourself
No calls on $BWXT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on BWX Technologies →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.